Oligonucleotides & Peptides: Why Your Sales Strategy Needs to Speak to Procurement
Over the last decade, oligonucleotides and peptides – collectively known as Tides – have evolved from niche molecules to mainstream players in drug development. With FDA approvals, booming CDMO pipelines, and innovative delivery platforms hitting the market, it’s no surprise that Tides are one of biotech’s fastest-growing segments. But here’s something less talked about – […]
Reasons to Attend a Tailored Life Science Conference
The life sciences field is rapidly evolving, with new discoveries and innovations continuously reshaping the landscape. For professionals in the field—whether researchers, clinicians, or business leaders—keeping up with the latest trends and developments is critical. One of the most effective ways to stay updated and gain a competitive edge is by attending specialized life science […]
CPHI 2024: Key Take Aways?
As one of the largest and most influential events in the pharmaceutical industry, CPHI (Convention on Pharmaceutical Ingredients) continues to be a focal point for professionals, innovators, and key stakeholders worldwide. The 2024 edition promises to be no different, bringing together experts from across the pharmaceutical supply chain to discuss cutting-edge trends, technological advancements, and […]
How Current Elections in the UK and USA Could Affect the CDMO Space
As the United States and the United Kingdom navigate their respective election seasons, stakeholders in various industries are closely monitoring potential policy changes and their impacts. The Contract Development and Manufacturing Organization (CDMO) sector, which plays a crucial role in pharmaceutical and biotechnology industries, is particularly sensitive to shifts in political climates. This article explores […]
Emerging Trends in Inhaled Drug Delivery
In the ever-evolving landscape of pharmaceuticals, inhaled drug delivery stands out as a dynamic and innovative field. The inhalation route offers a direct and targeted approach to drug administration, making it particularly appealing for respiratory conditions and beyond. As researchers and pharmaceutical companies delve deeper into this realm, several emerging trends are reshaping the way […]
The Evolution of Small Molecule CDMOs: The Complex Landscape of Drug Development
In the dynamic realm of pharmaceuticals, the evolution of Contract Development and Manufacturing Organisations (CDMOs) has played a crucial role in reshaping the landscape of drug development. Among these, Small Molecule CDMOs have emerged as key players, offering specialised services that facilitate the efficient and cost-effective production of pharmaceutical compounds. Let’s delve into the […]
Revolutionizing Healthcare: The Potential of Biotechnology
The intersection of science and life, known as Biotechnology, holds within its grasp the power to reshape the landscape of healthcare. By harnessing the intricate workings of living organisms, cells, and biological systems, Biotechnology pioneers a realm of possibilities for enhancing human health and overall well-being. This article delves into the myriad avenues through […]
Small Molecules and their Impact in Drug Discovery
Small Molecules play a crucial role in Drug Discovery and development. These are organic compounds with a relatively low molecular weight, typically less than 900 daltons. Here are some key aspects of Small Molecules and their Impact in Drug Discovery: Target Identification and Validation: Small molecules are used to identify and validate potential drug targets, […]
The Increasing Importance of CDMOs in the Pharmaceutical Industry
CDMOs (Contract Development and Manufacturing Organisations) play a crucial role in the pharmaceutical industry by providing a range of services to support the development and production of pharmaceutical and biopharmaceutical products. CDMOs offer expertise in areas such as drug discovery and development, clinical trials, process development and scale-up, and commercial-scale manufacturing. They can help […]